Since this publication, however, PRIME CARE, the largest controlled study to date that enrolled 1944 participants, more than the five studies of the meta-analysis combined, did not achieve significance on their co-primary outcome measure -predicted drug-gene interaction prescription and remission of depression [ 5 ].
← all excerpts
Reply to Sun: Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection.
1
—
—